Skip to main content

Table 2 Results of the digitalMLPA BRCA1 classifier in the training and test sets

From: BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

 

Predicted with digitalMLPA

Class error rate (%)

BRCA1-like

Non-BRCA1-like

Array-based score

Training set

  BRCA1-like

41

0

0

  Non-BRCA1-like

1

29

3

  Overall error rate

  

1

Test set

  BRCA1-like

39

3

7

  Non-BRCA1-like

3

25

10

  Overall error rate

  

9

Performance in the test set

  Sensitivity = 93%

   

  Specificity = 90%

   

  Accuracy = 91%

  Â